New mass spec innovation could transform research

(Press-News.org) Weight says a lot. In the kitchen, it could mean cooking with too little or too much of an ingredient. For scientists, a molecule’s weight can help determine its makeup. This, in turn, can shed light on whether a potential drug is acting on the body or not working at all. Weight can even reveal what tumors are made of, potentially influencing treatment options. For measures like this and more, researchers turn to a technique called mass spectrometry.

“A mass spectrometer is essentially a very precise scale,” says Cold Spring Harbor Laboratory (CSHL) Research Associate Professor Paolo Cifani. “Imagine a bucket full of different molecules. Using mass spectrometry, you can figure out what molecules and how many are in that bucket. This enables researchers to try to answer questions like, ‘Are there different proteins, lipids, or other small molecules in one tumor versus another?’”

Now, Cifani and his team at CSHL’s Mass Spectrometry facility have developed a new technique to push the performance of their instruments. Their innovation may improve drug target discovery while helping scientists answer long-standing questions about human health and biology.

When trying to identify molecules in complex mixtures, mass spectrometer sensitivity was thought to be determined almost exclusively by speed. Typical scans involve transferring molecules to a gaseous state. Their ions are then measured in sequence by taking “snapshots” inside the “bucket” every few seconds. However, if too many ions accumulate, they can start interacting, which messes up the scan. So, “it seems intuitive that the faster you go, the more you can sequence,” Cifani says.

“Speed is always a factor,” he explains. “But potentially interesting molecules can be overlooked because they’re not seen in the snapshot, as the spectrometer gets ‘blinded’ by more abundant ions. Our new technique looks to remedy that.”

Cifani likens it to a sorting system. Rather than measuring everything in the chamber at once, the Cifani lab breaks scans down into “bins.” If there’s a molecule at much higher levels, it only fills one bin, not the others.

“Our method is much better at measuring differences in concentration,” he says. “That’s very important when studying a drug versus a placebo.”

The lab is now working to refine and expand access to their new technique. Sharing it in the journal Analytical Chemistry is an important first step. Many CSHL core facilities offer technical expertise not only to researchers at the Laboratory but also to other institutions. Cifani and his team are confident their technique will be valuable to the scientific community. “This is a proof of concept,” he says. “We’re ready to inspire discovery, worldwide.”

END